Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Fish and Richardson
Mallinckrodt
Queensland Health
Teva
Federal Trade Commission
Express Scripts
US Department of Justice
McKesson

Generated: November 14, 2018

DrugPatentWatch Database Preview

Mylan Asi Company Profile

« Back to Dashboard

What is the competitive landscape for MYLAN ASI, and what generic and branded alternatives to MYLAN ASI drugs are available?

MYLAN ASI has eighteen approved drugs.



Summary for Mylan Asi
US Patents:0
Tradenames:15
Ingredients:14
NDAs:18

Drugs and US Patents for Mylan Asi

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Asi SUMATRIPTAN SUCCINATE sumatriptan succinate INJECTABLE;SUBCUTANEOUS 090641-001 Jul 28, 2010 AP RX No No ➤ Sign Up ➤ Sign Up
Mylan Asi AZITHROMYCIN azithromycin INJECTABLE;INJECTION 065506-001 Mar 24, 2009 AP RX No No ➤ Sign Up ➤ Sign Up
Mylan Asi LORAZEPAM lorazepam INJECTABLE;INJECTION 200542-002 Apr 28, 2017 DISCN No No ➤ Sign Up ➤ Sign Up
Mylan Asi ROPIVACAINE HYDROCHLORIDE ropivacaine hydrochloride SOLUTION;INJECTION 090318-004 Sep 23, 2014 AP RX No No ➤ Sign Up ➤ Sign Up
Mylan Asi BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 091487-002 Oct 18, 2011 AP RX No No ➤ Sign Up ➤ Sign Up
Mylan Asi BACITRACIN bacitracin INJECTABLE;INJECTION 090211-001 May 11, 2010 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Argus Health
Deloitte
Boehringer Ingelheim
US Department of Justice
Fish and Richardson
Baxter
Merck
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.